RxDoctor Payments Data

Ayanna Galloway, PA

Physician Assistant · Roanoke Rapids, NCNPI 1144291410

Payments from drug & device makers

$1,832in general payments, 2019–2025

Across 98 payments — averaging $18.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Corcept Therapeutics$317
  • GSK$295
  • Abbott$160
  • Novo Nordisk$150
  • AstraZeneca$143
  • Boehringer Ingelheim$97
  • plus $672 from 18 others

What the payments were for

  • Food & beverage$1,832100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,832 in reported general payments places this provider in the 80th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$7,013
Medicare patients
83
Services billed
180

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide68$65,716
FarxigaDapagliflozin Propanediol70$59,511
EliquisApixaban52$41,115
JardianceEmpagliflozin37$31,912
Trelegy ElliptaFluticasone/Umeclidin/Vilanter36$29,337
RybelsusSemaglutide16$21,493
LinzessLinaclotide15$15,252
Tresiba Flextouch U-200Insulin Degludec11$14,956
EntrestoSacubitril/Valsartan11$12,487
JanuviaSitagliptin Phosphate16$11,907
Tresiba Flextouch U-100Insulin Degludec24$10,817
XareltoRivaroxaban11$7,951
Spiriva HandihalerTiotropium Bromide14$5,921
SymbicortBudesonide/Formoterol Fumarate18$4,178
Incruse ElliptaUmeclidinium Bromide12$4,178

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$150$87,20984 claims
AstraZenecaFarxiga, Symbicort$143$63,68988 claims
PfizerEliquis$48$41,11552 claims
GSKTrelegy Ellipta, Incruse Ellipta$295$33,51548 claims
Boehringer IngelheimJardiance$97$31,91237 claims
AbbVieLinzess$32$15,25215 claims
NovartisEntresto$14$12,48711 claims
MerckJanuvia$56$11,90716 claims
Johnson & JohnsonXarelto$32$7,95111 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Roanoke Rapids

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →